SCHEMBL4126671

SCHEMBL4126671

COc1ccc(CN2CCC(CCc3noc4c(CN(C)C)c(OCC5CC5)ccc34)CC2)cc1

nearest known ligand 0.54

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ACHE P22303 15/20 0.54
BCHE P06276 2/20 0.43
FAAH O00519 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4120302 0.99 ACHE (0.53) ACHEBCHEFAAH
SCHEMBL4121355 0.92 ACHE (0.51) ACHEBCHE
Hydrochloric Acid SCHEMBL4125664 0.91 ACHE (0.51) ACHEBCHE
SCHEMBL4121328 0.91 ACHE (0.51) ACHEBCHE
SCHEMBL4124695 0.91 ACHE (0.61) ACHEBCHE
SCHEMBL4120890 0.91 ACHE (0.55) ACHEBCHEFAAH
Hydrochloric Acid SCHEMBL4125026 0.90 ACHE (0.50) ACHEBCHE
Hydrochloric Acid SCHEMBL4126182 0.90 ACHE (0.60) ACHEBCHE
Hydrochloric Acid SCHEMBL4121688 0.90 ACHE (0.55) ACHEBCHEFAAH
SCHEMBL4125672 0.90 ACHE (0.50) ACHEBCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090318690-A1 Benzisoxazole Compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-12-24 US disclosed
US-20090318690-A1 Benzisoxazole Compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-12-24 US disclosed
US-20090318690-A1 Benzisoxazole Compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-12-24 US disclosed
EP-2017275-A1 BENZISOXAZOLE COMPOUND Eisai R&D Management Co., Ltd. (JP) 2009-01-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090318690-A1 Benzisoxazole Compound NR1I2, NR1I3, NR0B1 ACHE 3716/4885BCHE 2215/4885FAAH 2433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.